4.7 Article Proceedings Paper

Computed tomography versus magnetic resonance imaging-based contouring in cervical cancer brachytherapy: Results of a prospective trial and preliminary guidelines for standardized contours

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.ijrobp.2006.12.021

关键词

cervical cancer; brachytherapy; computed tomography; magnetic resonance imaging

资金

  1. NCI NIH HHS [1K07 CA117979-01] Funding Source: Medline
  2. NATIONAL CANCER INSTITUTE [K07CA117979] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Purpose: To compare the contours and dose-volume histograms (DVH) of the tumor and organs at risk (OAR) with computed tomography (CT) vs. magnetic resonance imaging (MRI) in cervical cancer brachytherapy. Methods and Materials: Ten patients underwent both MRI and CT after applicator insertion. The dose received by at least 90% of the volume (D-90), the minimal target dose (D-100), the volume treated to the prescription dose or greater for tumor for the high-risk (HR) and intermediate-risk (IR) clinical target volume (CTV) and the dose to 0.1 cm(3), 1 cm(3), and 2 cm(3) for the OARs were evaluated. A standardized approach to contouring on CT (CTStd) was developed, implemented (HR- and IR-CTVCTStd), and compared with the MRI contours. Results: Tumor height, thickness, and total volume measurements, as determined by either CT or CTStd were not significantly different compared with the MRI volumes. In contrast, the width measurements differed in HR-CTVCTStd (p = 0.05) and IR-CTVCTStd(p = 0.01). For the HR-CTVCTStd, this resulted in statistically significant differences in the volume treated to the prescription dose or greater (MRI, 96% vs. CTStd, 86 %, p = 0.01), D-100 (MRI, 5.4 vs. CTStd, 3.4, p < 0.01), and D-90 (MRI, 8.7 vs. CTStd, 6.7, p < 0.01). Correspondingly, the IR-CTV DVH values on MRI vs. CTStd, differed in the D-100 (MRI, 3.0 vs. CTStd, 2.2, p = 0.01) and D-90 (MRI, 5.6 vs. CTStd, 4.6, p = 0.02). The MRI and CT DVH values of the dose to 0.1 cm(3), 1 cm(3), and 2 cm(3) for the OARs were similar. Conclusion: Computed tomography-based or MRI-based scans at brachytherapy are adequate for OAR DVH analysis. However, CT tumor contours can significantly overestimate the tumor width, resulting in significant differences in the D90, D100, and volume treated to the prescription dose or greater for the HR-CTV compared with that using MRI. MRI remains the standard for CTV definition. (C) 2007 Elsevier Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据